FDA Approves Brentuximab for 2 Types of Lymphoma
Links shared publicly online about this topic.
- 60total visits
FDA Approves Brentuximab for 2 Types of Lymphoma
View full resource at onclive.com
Tags: Cancer, Lymphoma, Hodgkin Lymphoma, FDA
Most Recently Shared on August 21, 2011 at 3:34 am By:
#oncology 2 FDA approvals in 1 week: vemurafenib http://t.co/nu4DP7E and brentuximab http://t.co/wDSpobT
New Lymphoma Drug Gives Patients Hope : Healthymagination
healthymagination.com — “In August, the Food and Drug Administration (FDA) approved Adcetris (brentuximab vedotin), the first new drug approved to treat Hodgkin lymphoma (HL) in the last 30 years.” View full resource at healthymagination.com
Most Recently Shared on January 23, 2012 at 5:01 pm By:
Herpes on Healthline Health Site
A new drug gives Hodgkin Lymphoma patients renewed hope: http://t.co/iAI2F0a5
FDA approves Seattle Genetics drug for 2 cancers - Forbes.com
forbes.com — “FDA approves Seattle Genetics drug for 2 cancers - Forbes.com” View full resource at forbes.com
Most Recently Shared on August 23, 2011 at 12:25 am By:
Thomas J Reid MD PhD Physician, Doctor, PhD, Internist, Oncologist, and Hematologist
FDA approves Adcetris (brentuximab) to treat Hodgkin's lymphoma and systemic anaplastic large cell lymphoma. http://t.co/nd8JrjN
PharmaLive: Seattle Genetics Announces FDA Accelerated Approval of Adcetris (Brentuximab Vedotin) for Two Indications
pharmalive.com — “PharmaLive: Seattle Genetics Announces FDA Accelerated Approval of Adcetris (Brentuximab Vedotin) for Two Indications” View full resource at pharmalive.com
Most Recently Shared on August 22, 2011 at 8:01 pm By:
PharmaLive Pharma and Health News
Daily Advantage - Seattle Genetics Hodgkin Lymphoma Drug OK'd - http://t.co/2znxYAb
FDA Approves Adcetris To Treat Two Types Of Lymphoma
medicalnewstoday.com — “The U.S. Food and Drug Administration approved Adcetris (brentuximab vedotin) to treat Hodgkin lymphoma (HL) and a rare lymphoma known as systemic anaplastic large cell lymphoma (ALCL).” View full resource at medicalnewstoday.com
Most Recently Shared on August 20, 2011 at 7:05 am By:
FDA Approves Adcetris To Treat Two Types Of Lymphoma http://mnt.to/3Z5T #lymphoma #leukemia
FDA Approves Adcetris to Treat Two Types of Lymphoma
drugs.com — “Adcetris (brentuximab vedotin) is used to treat Hodgkin lymphoma and systemic anaplastic large cell lymphoma . Includes Adcetris side effects, interactions and indications.” View full resource at drugs.com
Most Recently Shared on August 19, 2011 at 9:09 pm By:
Drugs and Devices OW OW Health
FDA Approves Adcetris to Treat Two Types of Lymphoma: August 19, 2011 - The U.S. Food and Drug Administrat... http://t.co/QLmCG1d #drug
FDA Approves Adcetris to Treat Two Types of Lymphoma
drugs.com — “Adcetris (brentuximab vedotin) is used to treat Hodgkin lymphoma and systemic anaplastic large cell lymphoma . Includes Adcetris side effects, interactions and indications.” View full resource at drugs.com
Most Recently Shared on August 19, 2011 at 8:34 pm By:
FDA Approves Adcetris to Treat Two Types of Lymphoma - http://t.co/4maXtfp
NCI Cancer Bulletin for July 26, 2011 - National Cancer Institute
cancer.gov — “NCI Cancer Bulletin for July 26, 2011 - National Cancer Institute” View full resource at cancer.gov
Most Recently Shared on July 27, 2011 at 9:15 pm By:
NCI Cancer Bulletin Health News
FDA Update: Advisory panel recommends accelerated approval for brentuximab for 2 types of lymphoma http://j.mp/r6vRw6
Seattle Genetics Announces Unanimous Recommendations from FDA Advisory Committee in Favor of Accelerated Approval of Adcetris for Post-Transplant Relapsed Hodgkin Lymphoma and Relapsed or Refractory Systemic ALCL
drugs.com — “Adcetris (brentuximab vedotin) is a new drug in development for the treatment of Hodgkin's lymphoma and anaplastic large cell lymphoma. Adcetris information includes news, clinical trial results and side effects.” View full resource at drugs.com
Most Recently Shared on July 15, 2011 at 11:14 pm By:
Drugs and Devices OW OW Health
Seattle Genetics Announces Unanimous Recommendations from FDA Advisory Committee in Favor of Accelerated A... http://bit.ly/n2iblP #drug
FDA Panel Unanimously Supports New Lymphoma Treatment
onclive.com — “ODAC unanimously recommended accelerated approval for brentuximab vedotin (Adcetris) in 2 types of lymphoma.” View full resource at onclive.com
Most Recently Shared on July 15, 2011 at 9:29 pm By:
FDA Panel Unanimously Supports New Lymphoma Treatment http://t.co/lGDEUrK
Seattle Genetics says FDA is reviewing cancer drug - seattlepi.com
seattlepi.com — “(AP) --" Seattle Genetics Inc. said Monday the Food and Drug Administration is now reviewing its experimental cancer drug as a treatment for Hodgkin's disease and a type of lymphoma. Seattle Genetics filed for marketing approval of the drug, called brentuximab, as a treatment for patients whose cancer did not respond to other drugs or has returned after previous treatment. Systemic ALCL is an aggressive type of non-Hodgkin's lymphoma diagnosed in about 2,000 people a year in the U.S. Seattle Gen” View full resource at seattlepi.com
Most Recently Shared on May 2, 2011 at 10:08 pm By:
JanCerny, MD, PhD Physician, Doctor, PhD, Internist, Oncologist, and Hematologist
brentuximab being reviewed by the FDA http://ow.ly/4LC9w
FDA Approves First Drug for Treatment of Peripheral T-cell Lymphoma
fda.gov — “The U.S. Food and Drug Administration has approved Folotyn (pralatrexate), the first treatment for a form of cancer known as Peripheral T-cell Lymphoma (PTCL), an often aggressive type of non-Hodgkins lymphoma.” View full resource at fda.gov
Most Recently Shared on September 25, 2009 at 3:41 pm By:
eyeonfda Pharma and Health Lawyer
FDA Approves First Drug for Treatment of Peripheral T-cell Lymphoma http://bit.ly/UPi2v
Advertisement
